Search details
1.
In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles.
Adv Exp Med Biol
; 1295: 271-299, 2021.
Article
in English
| MEDLINE | ID: mdl-33543464
2.
Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review.
Nanomedicine
; 28: 102206, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32334097
3.
Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity.
Exp Cell Res
; 370(1): 68-77, 2018 09 01.
Article
in English
| MEDLINE | ID: mdl-29902537
4.
Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.
Cell Mol Life Sci
; 71(8): 1417-38, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24221135
5.
Brain metastasis: An insight into novel molecular targets for theranostic approaches.
Crit Rev Oncol Hematol
; 198: 104377, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38710296
6.
Current Insights on Lipid-Based Nanosystems 2023.
Pharmaceuticals (Basel)
; 16(12)2023 Dec 08.
Article
in English
| MEDLINE | ID: mdl-38139826
7.
Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management.
Biomed Pharmacother
; 157: 114021, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36399831
8.
Development, characterization and in vitro evaluation of single or co-loaded imatinib mesylate liposomal formulations.
J Nanosci Nanotechnol
; 12(3): 2891-900, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22755139
9.
New advances in exosome-based targeted drug delivery systems.
Crit Rev Oncol Hematol
; 172: 103628, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35189326
10.
Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities.
Front Mol Biosci
; 9: 903065, 2022.
Article
in English
| MEDLINE | ID: mdl-36060249
11.
Editorial-Current Insights on Lipid-Based Nanosystems.
Pharmaceuticals (Basel)
; 15(10)2022 Oct 14.
Article
in English
| MEDLINE | ID: mdl-36297379
12.
Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma.
Int J Pharm
; 612: 121380, 2022 Jan 25.
Article
in English
| MEDLINE | ID: mdl-34915142
13.
Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells.
Eur J Pharm Biopharm
; 172: 61-77, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35104605
14.
Nucleolin expression has prognostic value in neuroblastoma patients.
EBioMedicine
; 85: 104300, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36209521
15.
Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancer.
Prostate
; 71(1): 81-90, 2011 Jan 01.
Article
in English
| MEDLINE | ID: mdl-20607721
16.
Supramolecular protamine/Gd-loaded liposomes adducts as relaxometric protease responsive probes.
Bioorg Med Chem
; 19(3): 1131-5, 2011 Feb 01.
Article
in English
| MEDLINE | ID: mdl-20719523
17.
Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis.
Pharmaceuticals (Basel)
; 14(1)2021 Jan 13.
Article
in English
| MEDLINE | ID: mdl-33451077
18.
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies.
Acta Pharm Sin B
; 11(4): 925-940, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33996407
19.
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN).
Pharmaceuticals (Basel)
; 14(8)2021 Jul 23.
Article
in English
| MEDLINE | ID: mdl-34451808
20.
Current challenges and emerging opportunities of CAR-T cell therapies.
J Control Release
; 319: 246-261, 2020 03 10.
Article
in English
| MEDLINE | ID: mdl-31899268